Cappuccio, Antonietta
,
Napolitano, Silvia http://orcid.org/0000-0001-5310-2738
Menzella, Francesco
Pellegrini, Guido
Policreti, Alessandro
Pelaia, Girolamo
Porpiglia, Pasquale Alberto
Marini, Maria Giulia
Article History
Received: 17 April 2019
Accepted: 6 June 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: The study was approved by the Ethics committee of Section Center Area of Calabria Region based at the A.O.U. Mater Domini in Via Tommaso Campanella, 115, Catanzaro (approval with protocol number n. 259), and informed written consent was obtained from RSs.
: Not applicable.
: Menzella, Pellegrini, Cappuccio, Napolitano and Marini have no conflicts of interest to disclose. Pelaia hereby states to have received lecture fees and advisory board fees from: AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi, Dompè, GSK, Guidotti/Malesci, Menarini, Mundipharma, Novartis, TEVA, Zambon. Policreti and Porpiglia are employees of Novartis Italia.